A multicenter study of reference intervals for 15 laboratory parameters in Chinese children

Objective: To establish comprehensive laboratory reference intervals for Chinese children. Methods: This was a cross-sectional multicenter study. From June 2013 to December 2014, eligible healthy children aged from 6-month to 17-year were enrolled from 20 medical centers with informed consent. They...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Zhonghua er ke za zhi = Chinese journal of pediatrics. - 1960. - 56(2018), 11 vom: 02. Nov., Seite 835-845
1. Verfasser: Zhong, X H (VerfasserIn)
Weitere Verfasser: Ding, J, Zhou, J H, Yu, Z H, Sun, S Z, Bao, Y, Mao, J H, Yu, L, Li, Z H, Han, Z M, Song, H M, Jiang, X Y, Liu, Y L, Zhang, B L, Xia, Z K, Jin, C H, Zhu, G H, Wang, M, Feng, S P, Shen, Y, Huang, S M, Ma, Q S, Li, H X, Wang, X J, Ichihara, K, Yao, C, Dong, C Y
Format: Online-Aufsatz
Sprache:Chinese
Veröffentlicht: 2018
Zugriff auf das übergeordnete Werk:Zhonghua er ke za zhi = Chinese journal of pediatrics
Schlagworte:Journal Article Multicenter Study Child Multicenter study Reference interval Estradiol 4TI98Z838E Luteinizing Hormone 9002-67-9 Follicle Stimulating Hormone 9002-68-0
LEADER 01000caa a22002652 4500
001 NLM290255244
003 DE-627
005 20250224080818.0
007 cr uuu---uuuuu
008 231225s2018 xx |||||o 00| ||chi c
024 7 |a 10.3760/cma.j.issn.0578-1310.2018.11.009  |2 doi 
028 5 2 |a pubmed25n0967.xml 
035 |a (DE-627)NLM290255244 
035 |a (NLM)30392208 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a chi 
100 1 |a Zhong, X H  |e verfasserin  |4 aut 
245 1 2 |a A multicenter study of reference intervals for 15 laboratory parameters in Chinese children 
264 1 |c 2018 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 01.04.2019 
500 |a Date Revised 01.04.2019 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a Objective: To establish comprehensive laboratory reference intervals for Chinese children. Methods: This was a cross-sectional multicenter study. From June 2013 to December 2014, eligible healthy children aged from 6-month to 17-year were enrolled from 20 medical centers with informed consent. They were assessed by physical examination, questionnaire survey and abdominal ultrasound for eligibility. Fasting blood samples were collected and delivered to central laboratory. Measurements of 15 clinical laboratory parameters were performed, including estradiol (E2), testosterone(T), luteinizing hormone(LH), follicle-stimulating hormone(FSH), alanine transaminase(ALT), serum creatinine(Scr), cystatin C, immunoglobulin A(IgA), immunoglobulin G(IgG), immunoglobulin M(IgM), complement (C3, C4), alkaline phosphatase(ALP), uric acid(UA) and creatine kinase(CK). Reference intervals were established according to central 95% confidence intervals for reference population, stratified by age and sex. Results: In total, 2 259 children were enrolled. Finally, 1 648 children were eligible for this study, including 830 boys and 818 girls, at a mean age of 7.4 years. Age- and sex- specific reference intervals have been established for the parameters. Reference intervals of sex hormones increased gradually with age. Concentrations of ALT, cystatin C, ALP and CK were higher in children under 2 years old. Serum levels of sex hormones, creatinine, immunoglobin, CK, ALP and urea increased rapidly in adolescence, with significant sex difference. In addition, reference intervals were variable depending on assay methods. Concentrations of ALT detected by reagents with pyridoxal 5'-phosphate(PLP) were higher than those detected by reagents without PLP. Compared with enzymatic method, Jaffe assay always got higher results of serum creatinine, especially in children younger than 9 years old. Conclusion: This study established age- and sex- specific reference intervals, for 15 clinical laboratory parameters based on defined healthy children 
650 4 |a Journal Article 
650 4 |a Multicenter Study 
650 4 |a Child 
650 4 |a Multicenter study 
650 4 |a Reference interval 
650 7 |a Estradiol  |2 NLM 
650 7 |a 4TI98Z838E  |2 NLM 
650 7 |a Luteinizing Hormone  |2 NLM 
650 7 |a 9002-67-9  |2 NLM 
650 7 |a Follicle Stimulating Hormone  |2 NLM 
650 7 |a 9002-68-0  |2 NLM 
700 1 |a Ding, J  |e verfasserin  |4 aut 
700 1 |a Zhou, J H  |e verfasserin  |4 aut 
700 1 |a Yu, Z H  |e verfasserin  |4 aut 
700 1 |a Sun, S Z  |e verfasserin  |4 aut 
700 1 |a Bao, Y  |e verfasserin  |4 aut 
700 1 |a Mao, J H  |e verfasserin  |4 aut 
700 1 |a Yu, L  |e verfasserin  |4 aut 
700 1 |a Li, Z H  |e verfasserin  |4 aut 
700 1 |a Han, Z M  |e verfasserin  |4 aut 
700 1 |a Song, H M  |e verfasserin  |4 aut 
700 1 |a Jiang, X Y  |e verfasserin  |4 aut 
700 1 |a Liu, Y L  |e verfasserin  |4 aut 
700 1 |a Zhang, B L  |e verfasserin  |4 aut 
700 1 |a Xia, Z K  |e verfasserin  |4 aut 
700 1 |a Jin, C H  |e verfasserin  |4 aut 
700 1 |a Zhu, G H  |e verfasserin  |4 aut 
700 1 |a Wang, M  |e verfasserin  |4 aut 
700 1 |a Feng, S P  |e verfasserin  |4 aut 
700 1 |a Shen, Y  |e verfasserin  |4 aut 
700 1 |a Huang, S M  |e verfasserin  |4 aut 
700 1 |a Ma, Q S  |e verfasserin  |4 aut 
700 1 |a Li, H X  |e verfasserin  |4 aut 
700 1 |a Wang, X J  |e verfasserin  |4 aut 
700 1 |a Ichihara, K  |e verfasserin  |4 aut 
700 1 |a Yao, C  |e verfasserin  |4 aut 
700 1 |a Dong, C Y  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Zhonghua er ke za zhi = Chinese journal of pediatrics  |d 1960  |g 56(2018), 11 vom: 02. Nov., Seite 835-845  |w (DE-627)NLM136249191  |x 0578-1310  |7 nnns 
773 1 8 |g volume:56  |g year:2018  |g number:11  |g day:02  |g month:11  |g pages:835-845 
856 4 0 |u http://dx.doi.org/10.3760/cma.j.issn.0578-1310.2018.11.009  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_20 
912 |a GBV_ILN_22 
912 |a GBV_ILN_24 
912 |a GBV_ILN_31 
912 |a GBV_ILN_39 
912 |a GBV_ILN_40 
912 |a GBV_ILN_50 
912 |a GBV_ILN_61 
912 |a GBV_ILN_65 
912 |a GBV_ILN_69 
912 |a GBV_ILN_70 
912 |a GBV_ILN_72 
912 |a GBV_ILN_120 
912 |a GBV_ILN_130 
912 |a GBV_ILN_227 
912 |a GBV_ILN_244 
912 |a GBV_ILN_285 
912 |a GBV_ILN_294 
912 |a GBV_ILN_350 
912 |a GBV_ILN_665 
912 |a GBV_ILN_813 
951 |a AR 
952 |d 56  |j 2018  |e 11  |b 02  |c 11  |h 835-845